erlin2 mutations in two iranian families with hereditary spastic paraplegia
Authors
abstract
spastic paraplegia 18 is an autosomal recessive disorder characterized by motor dysfunction, joint contracture and mental retardation. we describe two families as three cases. case 1 is a 35-year-old woman with and spasticity and mild weakness in lower limbs. case 2 and 3 are a sister and brother aged six and two respectively. the older sister suffered from lower limb spasticity, equinovarus and weakness in lower and upper hands. the brother had spasticity in lower limbs. parents of both families were consanguineous. based on positive clinical findings hereditary spastic paraplegia (hsp) was suspected and targeted next generation sequencing was performed for genes responsible for hsp identifying a homozygote 37607361 ac>a mutation in erlin2. in cases 2 and 3 a homozygous mutation was identified by whole exome sequencing. to date all patients, except one, reported with erlin2 mutations have intellectual disability. our patient with normal intelligence, without additional findings highlights the fact that erlin2 mutations can present as uncomplicated hsp.
similar resources
Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia.
BACKGROUND Hereditary spastic paraplegia (HSP) is a neurodegenerative disease characterized by progressive spasticity and weakness of the lower limbs. The most common form of HSP is caused by mutations in the SPG4 gene, which codes for spastin, an adenosine triphosphatase with various cellular activities (AAA) protein family member. OBJECTIVE To investigate a large collection of predominantly...
full textHereditary spastic paraplegia.
Hereditary spastic paraplegia (HSP) or Strümpell-Lorrain syndrome is a heterogeneous group of inherited disorders, with prevalence ranged from 4.3 to 9.6 cases per 100,000 population. A common feature of these disorders is the slowly progressive and often severe spasticity, noticeably especially in the low limbs. Conventionally, HSP is divided into two clinical groups, uncomplicated (pure spast...
full textHereditary Spastic Paraplegia.
111 families, and Paskind and Stone (1933) also summarized the literature with accounts of another 36 reports from 40 families. Since then about 50 further reports have appeared, covering some 60 families, bringing the total so far to 176 reports of 215 families. Of these the majority have originated in Germany or elsewhere in Europe, but with a substantial number from the Americas. In Britain,...
full textHereditary "pure" spastic paraplegia: a study of nine families.
The genetic and clinical features of 46 patients in nine families with "pure" hereditary spastic paraplegia are described. Inheritance was autosomal dominant in seven families and autosomal recessive in two. In dominant kinships, five families corresponded to type I with onset below 35 years, and two to type II with onset over 35 years. In early onset dominant families, in spite of apparent com...
full textSPG3A gene polymorphisms in hereditary spastic paraplegia
Objective: This study aimed to analyze the hereditary spastic paraplegia (HSP)/spastic paraplegia 3A (SpG3A) genomic structure as well as the polymorphisms in SPG3G genomic structure by comparing with the normal subjects. Methods: A total of 66 sporadic cases with HSP were collected from April 2014 to September 2016. Genomic DNA extraction was performed, and all coding exons and junction region...
full textChild neurology: hereditary spastic paraplegia in children.
S.T. de Bot, MD B.P.C. van de Warrenburg, MD, PhD H.P.H. Kremer, MD, PhD M.A.A.P. Willemsen, MD, PhD Because the medical literature on hereditary spastic paraplegia (HSP) is dominated by descriptions of adult case series, there is less emphasis on the genetic evaluation in suspected pediatric cases of HSP. The differential diagnosis of progressive spastic paraplegia strongly depends on the age ...
full textMy Resources
Save resource for easier access later
Journal title:
genetics in the 3rd millenniumجلد ۱۴، شماره ۱، صفحات ۳۵-۳۵
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023